Amarin Corp Plcuk (AMRN) Cost of Revenue (2013 - 2026)

Amarin Corp Plcuk (AMRN) posted quarterly Cost of Revenue of $27.4 million for Q1 2026, up 270.57% YoY from $7.4 million in Q1 2025, and down 63.12% sequentially from $74.2 million in Q4 2025.

Amarin Corp Plcuk (AMRN) Cost of Revenue (2013 - 2026) Analysis & Trends

Amarin Corp Plcuk has disclosed Cost of Revenue across 14 years of filings, most recently posting $27.4 million for Q1 2026.

  • In Q1 2026, Cost of Revenue rose 270.57% year-over-year to $27.4 million; the TTM figure through Mar 2026 stood at $126.7 million (up 133.69% YoY), while the FY2025 annual figure was $92.8 million, up 131.08% from the prior year.
  • Cost of Revenue retreated to $27.4 million in Q1 2026, from $74.2 million in the prior quarter.
  • Over the last five years, Cost of Revenue for AMRN reached as high as $74.2 million in Q4 2025 and fell as low as -$15.3 million in Q4 2023.
  • The 5-year median for Cost of Revenue is $23.6 million (2023), against an average of $22.3 million.
  • Annual changes were most pronounced in 2023 — Cost of Revenue slumped 143.72% — and 2025, when it surged 601.88%.
  • A 5-year view of Cost of Revenue shows it stood at $35.0 million in 2022, then plunged by 143.72% to -$15.3 million in 2023, then surged by 169.05% to $10.6 million in 2024, then surged by 601.88% to $74.2 million in 2025, then sank by 63.12% to $27.4 million in 2026.
  • According to Business Quant data, Cost of Revenue over the past three periods registered $27.4 million, $74.2 million, and $2.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn 3.58 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn 8.11 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn 4.22 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn 2.68 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn 4.20 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn 2.74 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn 1.45 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn 3.55 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Amarin Corp Plcuk 5.17 Bn 5.00 Bn 17.77 Mn 27.36 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 27.36 Mn
Mar 31, 2026 27.36 Mn
Dec 31, 2025 74.20 Mn
Dec 31, 2025 74.20 Mn
Sep 30, 2025 2.72 Mn
Sep 30, 2025 2.72 Mn
Jun 30, 2025 22.38 Mn
Jun 30, 2025 22.38 Mn
Mar 31, 2025 7.38 Mn
Mar 31, 2025 7.38 Mn
Dec 31, 2024 10.57 Mn
Dec 31, 2024 10.57 Mn
Sep 30, 2024 26.02 Mn
Sep 30, 2024 26.02 Mn
Jun 30, 2024 10.22 Mn
Jun 30, 2024 10.22 Mn
Mar 31, 2024 24.62 Mn
Mar 31, 2024 24.62 Mn
Dec 31, 2023 -15.31 Mn
Dec 31, 2023 -15.31 Mn